304 related articles for article (PubMed ID: 30810692)
1. PRECORDIAL PAIN, LEUKOCYTOSIS AND BICYTOPENIA IN A TEENAGER WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS UNDER IMMUNOSUPPRESSIVE THERAPY.
Vieira MS; Andrade FR; Brandão LMKR; Nóbrega VTD; Guissa VR; Provenza JR
Rev Paul Pediatr; 2019; 37(2):252-256. PubMed ID: 30810692
[TBL] [Abstract][Full Text] [Related]
2. Plasma exchange successfully treated macrophage activation syndrome in rheumatoid factor-positive polyarticular juvenile idiopathic arthritis with co-existing pneumonia.
Shi L; Hu F; Xu C; Zhu H; Qie D; Yuan C; Tao Y; Liu H
Int J Rheum Dis; 2018 May; 21(5):1142-1145. PubMed ID: 28328098
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation syndrome in an inadequately treated patient with systemic onset juvenile idiopathic arthritis.
Juneja M; Jain R; Mishra D
Kathmandu Univ Med J (KUMJ); 2009; 7(28):411-3. PubMed ID: 20502084
[TBL] [Abstract][Full Text] [Related]
4. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases.
Lin CI; Yu HH; Lee JH; Wang LC; Lin YT; Yang YH; Chiang BL
Clin Rheumatol; 2012 Aug; 31(8):1223-30. PubMed ID: 22615046
[TBL] [Abstract][Full Text] [Related]
5. Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome.
Wagner-Weiner L
Pediatr Ann; 2015 Jun; 44(6):e142-7. PubMed ID: 26114369
[TBL] [Abstract][Full Text] [Related]
6. Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review.
Stewart JA; Price T; Moser S; Mullikin D; Bryan A
Pediatr Rheumatol Online J; 2022 Feb; 20(1):16. PubMed ID: 35193600
[TBL] [Abstract][Full Text] [Related]
7. [Macrophage activation syndrome associated with systemic juvenile idiopathic arthritis].
Silva CA; Silva CH; Robazzi TC; Lotito AP; Mendroni Junior A; Jacob CM; Kiss MH
J Pediatr (Rio J); 2004; 80(6):517-22. PubMed ID: 15622430
[TBL] [Abstract][Full Text] [Related]
8. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
9. Systemic Juvenile Idiopathic Arthritis.
Lee JJY; Schneider R
Pediatr Clin North Am; 2018 Aug; 65(4):691-709. PubMed ID: 30031494
[TBL] [Abstract][Full Text] [Related]
10. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Likhacheva TS; Isupova EA; Glebova NI; Kuchinskaya EM; Balbotkina EV; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
Semin Arthritis Rheum; 2015 Feb; 44(4):417-22. PubMed ID: 25300700
[TBL] [Abstract][Full Text] [Related]
11. Macrophage activation syndrome in pediatrics: 10 years data from an Indian center.
Pal P; Bathia J; Giri PP; Roy M; Nandi A
Int J Rheum Dis; 2020 Oct; 23(10):1412-1416. PubMed ID: 32666639
[TBL] [Abstract][Full Text] [Related]
12. Sudden Hypotension and Increased Serum Interferon-γ and Interleukin-10 Predict Early Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis.
Guo L; Xu Y; Qian X; Zou L; Zheng R; Teng L; Zheng Q; Leung Jung LK; Lu M
J Pediatr; 2021 Aug; 235():203-211.e3. PubMed ID: 33581106
[TBL] [Abstract][Full Text] [Related]
13. Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapy.
Nozawa T; Nishimura K; Ohara A; Hara R; Ito S
Mod Rheumatol; 2019 May; 29(3):558-562. PubMed ID: 27846755
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin therapy leading to dramatic improvement in a patient with systemic juvenile idiopathic arthritis and severe pericarditis resistant to steroid pulse therapy.
Aizawa-Yashiro T; Oki E; Tsuruga K; Nakahata T; Ito E; Tanaka H
Rheumatol Int; 2012 May; 32(5):1359-61. PubMed ID: 20237928
[TBL] [Abstract][Full Text] [Related]
15. Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis.
Zeng HS; Xiong XY; Wei YD; Wang HW; Luo XP
World J Pediatr; 2008 May; 4(2):97-101. PubMed ID: 18661762
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.
Reddy VV; Myles A; Cheekatla SS; Singh S; Aggarwal A
Int J Rheum Dis; 2014 Mar; 17(3):261-7. PubMed ID: 24417800
[TBL] [Abstract][Full Text] [Related]
17. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Takakura M; Shimizu M; Irabu H; Sakumura N; Inoue N; Mizuta M; Nakagishi Y; Yachie A
Clin Immunol; 2019 Nov; 208():108252. PubMed ID: 31449879
[TBL] [Abstract][Full Text] [Related]
18. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
[TBL] [Abstract][Full Text] [Related]
19. Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review.
Çakan M; Aktay-Ayaz N; Gemici H; Annayev A; Çıtak A; Akçay A; Öztürk G
Turk J Pediatr; 2018; 60(5):598-603. PubMed ID: 30968645
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Boom V; Anton J; Lahdenne P; Quartier P; Ravelli A; Wulffraat NM; Vastert SJ
Pediatr Rheumatol Online J; 2015 Dec; 13():55. PubMed ID: 26634252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
